Promoter Polymorphism of RGS2 Gene Is Associated with Change of Blood Pressure in Subjects with Antihypertensive Treatment: The Azelnidipine and Temocapril in Hypertensive Patients with Type 2 Diabetes Study
We performed a prospective study to examine the genetic effect on the response to a calcium (Ca) channel blocker, azelnidipine and an ACE inhibitor, temocapril treatment in patients with hypertension, as a part of the prior clinical trial, the Azelnidipine and Temocapril in Hypertensive Patients wit...
Saved in:
Main Authors: | Ken Sugimoto, Tomohiro Katsuya, Kei Kamide, Tomomi Fujisawa, Izumi Shimaoka, Mitsuru Ohishi, Ryuichi Morishita, Toshio Ogihara, Hiromi Rakugi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2010-01-01
|
Series: | International Journal of Hypertension |
Online Access: | http://dx.doi.org/10.4061/2010/196307 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Core-in-cup/liquisol dual tackling effect on azelnidipine buccoadhesive tablet micromeritics, in vitro release, and mucoadhesive strength
by: Rashad Amira A., et al.
Published: (2019-09-01) -
Essay: Endocrinology and my research life
by: Toshio Ogihara
Published: (2023-11-01) -
Adherence to Antihypertensive Medications in Iranian Patients
by: Azin Behnood-Rod, et al.
Published: (2016-01-01) -
CircWDR78 inhibits the development of colorectal cancer by regulating the miR-653-3p/RGS4 axis
by: Chu Hao, et al.
Published: (2025-02-01) -
Antihypertensive effect of sinapine extracted from rapeseed meal in 2K1C hypertensive rats
by: Gaoyuan Yang, et al.
Published: (2025-02-01)